New study shows Hemp Oz Kombucha can assist with controlling blood glucose levels

We are delighted to release the extraordinary results of a 12-day observational study to demonstrate the benefits of hemp-infused Kombucha for type-2 diabetes sufferers. Hemp Oz Kombucha was developed by John Leith, Founder and CEO of Oz Medicann Group, a licensed medicinal cannabis healthcare company headquartered in Australia, following a diagnosis of type 2 diabetes. … Read more

Oz Medicann Group’s Clinical Trial for Insomnia

Oz Medicann Group (OMG) an Australian CBD, Cannabis and Hemp Therapeutics company with a focus on research and the development of cannabinoid registered medicine, is a step closer to bringing effective insomnia solutions with the first trans-Tasman clinical trial using its unique CBD formula with the hope of bringing greater relief to insomniacs.